1. Brucella abortus induces mast cell activation through TLR-2 and TLR-4
   Adriana Dominguez-Flores et al, 2023, Microbial Pathogenesis CrossRef
2. Advancing the frontiers of adaptive cell therapy: A transformative mechanistic journey from preclinical to clinical settings
   Ashi Mannan et al, 2023, International Immunopharmacology CrossRef
3. Ruxolitinib does not completely abrogate the functional capabilities of TLR4/9 ligand-activated NK cells
   Carmen Mestre-Durán et al, 2023, Frontiers in Immunology CrossRef